Literature DB >> 27928743

Age effects in mortality risk valuation.

Raul Brey1, Jose Luis Pinto-Prades2,3.   

Abstract

We provide more evidence on the functional relationship between willingness-to-pay for risk reductions and age (the senior discount). We overcome many of the limitations of previous literature that has dealt with this issue, namely, the influence of the assumptions used in statistical models on the final results. Given our large sample size (n = 6024) we can use models that are very demanding on data. We use parametric (linear, quadratic, dummies), semi-nonparametric, and non-parametric models. We also compare the marginal and the total approach and show that they provide similar results. We also overcome one of the limitations of the total approach, that is, we include the effects of socioeconomic characteristics that are correlated with age (education and income). Our main result is that all these different approaches produce very similar results, namely, they show an inverted-U relation between the value of a statistical life (VSL) and age. Those results can hardly be attributed to problems of collinearity, omitted variables or statistical assumptions. We find a clear senior discount effect. This effect seems concentrated on those who have lower education and income levels. We also find that the value of a statistical life year (VSLY) increases with age.

Keywords:  Mortality risk valuation; Seniority effect; Value of statistical life; Willingness-to-pay

Mesh:

Year:  2016        PMID: 27928743     DOI: 10.1007/s10198-016-0852-8

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  5 in total

1.  What is a life worth? Robustness of VSL values from contingent valuation surveys.

Authors:  Anna Alberini
Journal:  Risk Anal       Date:  2005-08       Impact factor: 4.000

2.  Category judgment: a range-frequency model.

Authors:  A Parducci
Journal:  Psychol Rev       Date:  1965-11       Impact factor: 8.934

3.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

4.  The mortality cost to smokers.

Authors:  W Kip Viscusi; Joni Hersch
Journal:  J Health Econ       Date:  2008-02-02       Impact factor: 3.883

5.  Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone.

Authors:  Jose-Luis Pinto-Prades; Veronica Farreras; Jaime Fernandez de Bobadilla
Journal:  Eur J Health Econ       Date:  2007-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.